Adaptimmune Therapeutics PLC - Ordinary Shares (ADAP)

Q2 2015 13F Holders as of 6/30/2015

Type / Class: Equity / Ordinary Shares
Shares outstanding: 1.57B
Number of holders: 44
Total 13F shares, excl. options: 19.2M
Shares change: +18.7M
Total reported value, excl. options: $352M
Value change: +$343M
Number of buys: 43
Price: $18.33

Significant Holders of Adaptimmune Therapeutics PLC - Ordinary Shares (ADAP) as of Q2 2015

44 filings reported holding ADAP - Adaptimmune Therapeutics PLC - Ordinary Shares as of Q2 2015.
Adaptimmune Therapeutics PLC - Ordinary Shares (ADAP) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 19.2M shares of 1.57B outstanding shares and own 1.22% of the company stock.
Largest 10 shareholders include FMR LLC (6.17M shares), ORBIMED ADVISORS LLC (4.41M shares), Foresite Capital Management II, LLC (1.76M shares), Capital World Investors (1.09M shares), Partner Fund Management, L.P. (966K shares), Rock Springs Capital Management LP (905K shares), ARROWGRASS CAPITAL PARTNERS (US) LP (479K shares), QVT Financial LP (350K shares), JENNISON ASSOCIATES LLC (350K shares), and ADAGE CAPITAL PARTNERS GP LLC (300K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.